Blue Cross And Blue Shield Association v. Jazz Pharmaceuticals PLC et al
| Blue Cross And Blue Shield Association |
| Lupin Inc., Roxane Laboratories, Inc., Lupin Ltd., Jazz Pharmaceuticals, Inc., Eurohealth (USA), Inc., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Hikma Pharmaceuticals USA, Inc., PAR Pharmaceutical, Inc., Jazz Pharmaceuticals Ireland Limited, Amneal Pharmaceuticals LLC and Jazz Pharmaceuticals PLC |
| 1:2020cv03543 |
| June 17, 2020 |
| US District Court for the Northern District of Illinois |
| Joan B Gottschall |
| Anti-Trust |
| 15 U.S.C. ยง 15 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 15, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 MINUTE entry before the Honorable Joan B. Gottschall: Pursuant to the plaintiff's amended notice of voluntary dismissal #8 , this case is dismissed without prejudice to any rights that plaintiff may have individually or to its rights as a member of the proposed putative class. Civil case terminated. Mailed notice (mjc, ) |
| Filing 8 NOTICE of Voluntary Dismissal by Blue Cross And Blue Shield Association Amended Notice of Voluntary Dismissal of Plaintiff Pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i) (Kurowski, Daniel) |
| Filing 7 MINUTE entry before the Honorable Joan B. Gottschall: Plaintiff's notice #6 , titled "Notice of Voluntary Dismissal of Plaintiff Blue Cross and Blue Shield Association Pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i)," states that plaintiff "voluntarily dismisses itself from the above-captioned litigation." It is not completely clear whether plaintiff means to dismiss this case in its entirety, as Fed. R. Civ. P. 41(a)(1)(A)(i) provides, or to dismiss itself as a party plaintiff and leave this putative class action pending. Absent communication to the contrary from plaintiff on or before July 16, 2020, this court will assume that plaintiff intends to dismiss this action in its entirety, and this case will be dismissed without prejudice and without further court order effective July 17, 2020. Mailed notice (mjc, ) |
| Filing 6 NOTICE of Voluntary Dismissal by Blue Cross And Blue Shield Association Pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i) (Kurowski, Daniel) |
Filing 5
ORDER Fifth Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on July 10, 2020. This Order does not extend or modify any deadlines set in civil cases. No motions may be noticed for in-person presentment; the presiding judge will notify parties of the need, if any, for a hearing by electronic means or in-court proceeding. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 7/10/2020: Mailed notice. (Clerk10, Docket)
|
|
Filing 4
ORDER: An initial status report and, if appropriate, case management plan is due on or before September 2, 2020. The parties are directed to consult Judge Gottschall's website for specific requirements for all written status reports and for the discovery plans. In conformity with Fourth Amended General Order 20-12 and due to the need for social distancing during the COVID-19 pandemic, this court is ordering written status reports instead of routine oral status hearings. This includes initial status hearings and scheduling conferences under Fed. R. Civ. P. 16(b). See Judge Gottschall's website for the procedure for requesting a hearing. No Rule 26(f) discovery plan should be submitted until all defendants have been served. If all defendants have not been served by the deadline for filing an initial status report, the report should so state and propose a deadline for filing a discovery plan. The parties are directed to discuss settlement and whether they consent to proceed before the Magistrate Judge. They are further directed to meet and confer regarding a proposed discovery plan. See Judge Gottschall's civil case management packet regarding pretrial case management procedures at: http://www.ilnd.uscourts.gov. Signed by the Honorable Joan B. Gottschall on 7/1/2020. Mailed notice(mjc, )
|
| ALIAS Summons Issued as to Defendant Hikma Pharmaceuticals USA, Inc.. (daj, ) |
| SUMMONS Issued as to Defendants Amneal Pharmaceuticals LLC, Eurohealth (USA), Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA, Inc., Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals PLC, Jazz Pharmaceuticals, Inc., Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., PAR Pharmaceutical, Inc., Roxane Laboratories, Inc. (ng, ) |
| Filing 3 ATTORNEY Appearance for Plaintiff Blue Cross And Blue Shield Association by Whitney Kendall Siehl (Siehl, Whitney) |
| Filing 2 ATTORNEY Appearance for Plaintiff Blue Cross And Blue Shield Association by Daniel J. Kurowski (Kurowski, Daniel) |
| Filing 1 COMPLAINT filed by Blue Cross And Blue Shield Association; Jury Demand. Filing fee $ 400, receipt number 0752-17118447. (Attachments: #1 Civil Cover Sheet)(Kurowski, Daniel) |
| CASE ASSIGNED to the Honorable Joan B. Gottschall. Designated as Magistrate Judge the Honorable Beth W. Jantz. Case assignment: Random assignment. (gw, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
